{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:21:35Z","timestamp":1789410095988,"version":"build-2803163510"},"reference-count":80,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["24390227"],"award-info":[{"award-number":["24390227"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["24659437"],"award-info":[{"award-number":["24659437"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["26461298"],"award-info":[{"award-number":["26461298"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"publisher","award":["23-4"],"award-info":[{"award-number":["23-4"]}],"id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"publisher","award":["23-5"],"award-info":[{"award-number":["23-5"]}],"id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.autrev.2017.05.003","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T06:31:34Z","timestamp":1493879494000},"page":"693-700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Integrated Diagnosis Project for Inflammatory Myopathies: An association between autoantibodies and muscle pathology"],"prefix":"10.1016","volume":"16","author":[{"given":"Shigeaki","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Uruha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichizo","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2017.05.003_bb0005","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMc1506827","article-title":"Inflammatory muscle diseases","volume":"373","author":"Dalakas","year":"2015","journal-title":"N Engl J Med"},{"issue":"Suppl. 2","key":"10.1016\/j.autrev.2017.05.003_bb0010","doi-asserted-by":"crossref","first-page":"i82","DOI":"10.1136\/annrheumdis-2011-200587","article-title":"New approaches to the assessment and treatment of the idiopathic inflammatory myopathies","volume":"71","author":"Miller","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.003_bb0015","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.nmd.2014.12.001","article-title":"205th ENMC International Workshop: pathology diagnosis of idiopathic inflammatory myopathies part II 28\u201330 March 2014, Naarden, The Netherlands","volume":"25","author":"De Bleecker","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.autrev.2017.05.003_bb0020","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.05.003_bb0025","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2017.05.003_bb0030","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10\u201312 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.autrev.2017.05.003_bb0035","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.autrev.2014.03.004","article-title":"The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome","volume":"13","author":"Lega","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.05.003_bb0040","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/BOR.0b013e3282f01a8c","article-title":"Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance","volume":"19","author":"Mimori","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.003_bb0045","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jneuroim.2014.07.006","article-title":"Clinical and histological findings associated with autoantibodies detected by RNA immunoprecipitation in inflammatory myopathies","volume":"274","author":"Suzuki","year":"2014","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2017.05.003_bb0050","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1136\/jnnp-2016-313166","article-title":"Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy","volume":"87","author":"Watanabe","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2017.05.003_bb0055","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.autrev.2014.01.016","article-title":"Diagnosis and classification of sporadic inclusion body myositis (sIBM)","volume":"13","author":"Catalan","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.05.003_bb0060","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1093\/brain\/awr213","article-title":"Long-term observational study of sporadic inclusion body myositis","volume":"134","author":"Benveniste","year":"2011","journal-title":"Brain"},{"issue":"61","key":"10.1016\/j.autrev.2017.05.003_bb0065","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/WNL.61.3.316","article-title":"Polymyositis: an overdiagnosed entity","volume":"12","author":"van der Meulen","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2017.05.003_bb0070","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaut.2014.01.025","article-title":"The diagnosis and classification of polymyositis","volume":"48\u201349","author":"Milisenda","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.05.003_bb0075","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/WCO.0b013e328364e9d9","article-title":"Acquired necrotizing myopathies","volume":"26","author":"Allenbach","year":"2013","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2017.05.003_bb0080","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2990.2012.01302.x","article-title":"Review: immune-mediated necrotizing myopathies\u2014a heterogeneous group of diseases with specific myopathological features","volume":"38","author":"Stenzel","year":"2012","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.autrev.2017.05.003_bb0085","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/archneurol.2011.1728","article-title":"Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome","volume":"69","author":"Suzuki","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2017.05.003_bb0090","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/rheumatology\/kew386","article-title":"Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl\u2013coenzyme A reductase antibodies","volume":"56","author":"Liang","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.05.003_bb0095","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/CND.0000000000000115","article-title":"Chronic myopathy associated with anti-signal recognition particle antibodies can be misdiagnosed as fascioscapulohumeral muscular dystrophy","volume":"17","author":"Ikeda","year":"2016","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.autrev.2017.05.003_bb0100","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.autrev.2014.01.022","article-title":"Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review","volume":"13","author":"Mahler","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.05.003_bb0105","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0889-857X(21)00737-7","article-title":"Autoantibodies in polymyositis","volume":"18","author":"Targoff","year":"1992","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2017.05.003_bb0110","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1093\/brain\/awv192","article-title":"Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis","volume":"138","author":"Mescam-Mancini","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2017.05.003_bb0115","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/aww125","article-title":"Perifascicular necrosis in anti-synthetase syndrome beyond anti-Jo-1","volume":"139","author":"Uruha","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2017.05.003_bb0120","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/jnnp.68.4.472","article-title":"Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres","volume":"68","author":"Mozaffar","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2017.05.003_bb0125","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.0000000000001422","article-title":"Nuclear actin aggregation is a hallmark of anti-synthetase syndrome-induced dysimmune myopathy","volume":"84","author":"Stenzel","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2017.05.003_bb0130","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s40478-014-0154-2","article-title":"Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy","volume":"2","author":"Aouizerate","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.autrev.2017.05.003_bb0135","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.autrev.2014.08.011","article-title":"Four dermatomyositis-specific autoantibodies-anti-TIF1gamma, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort","volume":"13","author":"Bodoki","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.05.003_bb0140","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jaut.2013.11.005","article-title":"The clinical features, diagnosis and classification of dermatomyositis","volume":"48\u201349","author":"Iaccarino","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.05.003_bb0145","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2017.05.003_bb0150","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1212\/WNL.0000000000003568","article-title":"Sarcoplasmic MxA expression","volume":"88","author":"Uruha","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2017.05.003_bb0155","first-page":"1615","article-title":"Inflammatory myopathies","volume":"19","author":"Amato","year":"2013","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.autrev.2017.05.003_bb0160","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/art.1780281207","article-title":"Detection of antibodies to small nuclear ribonucleoproteins and small cytoplasmic ribonucleoproteins using unlabeled cell extracts","volume":"28","author":"Forman","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.003_bb0165","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1073\/pnas.76.11.5495","article-title":"Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus","volume":"76","author":"Lerner","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2017.05.003_bb0170","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1093\/rheumatology\/keq281","article-title":"Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay","volume":"49","author":"Ghirardello","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.05.003_bb0175","doi-asserted-by":"crossref","first-page":"9507","DOI":"10.1073\/pnas.83.24.9507","article-title":"Human autoantibodies reactive with the signal-recognition particle","volume":"83","author":"Reeves","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2017.05.003_bb0180","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.autrev.2013.07.001","article-title":"Statin-induced necrotizing myositis - a discrete autoimmune entity within the \u201cstatin-induced myopathy spectrum\u201d","volume":"12","author":"Hamann","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.05.003_bb0185","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.autrev.2016.07.023","article-title":"Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: a history of statins and experience from a large international multi-center study","volume":"15","author":"Musset","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.05.003_bb0190","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","article-title":"Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy","volume":"63","author":"Mammen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.003_bb0195","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1212\/WNL.0000000000003160","article-title":"HLA-DRB1 alleles in immune-mediated necrotizing myopathy","volume":"87","author":"Ohnuki","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2017.05.003_bb0200","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13023-015-0277-y","article-title":"Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients","volume":"10","author":"Suzuki","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.autrev.2017.05.003_bb0205","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/art.30344","article-title":"Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy","volume":"63","author":"Benveniste","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.003_bb0210","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/rheumatology\/ken325","article-title":"Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies","volume":"47","author":"Suzuki","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.05.003_bb0215","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000416","article-title":"Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase autoantibodies: an observational study in Japan","volume":"94","author":"Watanabe","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2017.05.003_bb0220","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/acr.20662","article-title":"Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects","volume":"64","author":"Mammen","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2017.05.003_bb0225","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/MD.0000000000000028","article-title":"Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin","volume":"93","author":"Allenbach","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2017.05.003_bb0230","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1002\/art.34673","article-title":"Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy","volume":"64","author":"Werner","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.003_bb0235","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.autrev.2016.09.005","article-title":"Statin-associated autoimmune myopathy: a distinct new IFL pattern can increase the rate of HMGCR antibody detection by clinical laboratories","volume":"15","author":"Alvarado-Cardenas","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.05.003_bb0240","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pediatrneurol.2011.04.009","article-title":"Anti-signal recognition particle myopathy in the first decade of life","volume":"45","author":"Suzuki","year":"2011","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.autrev.2017.05.003_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060442","article-title":"Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome","volume":"8","author":"Hamaguchi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.05.003_bb0250","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/annrheumdis-2012-201800","article-title":"Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients","volume":"73","author":"Aggarwal","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.003_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085062","article-title":"The multicenter study of a new assay for simultaneous detection of multiple anti-aminoacyl-tRNA synthetases in myositis and interstitial pneumonia","volume":"9","author":"Nakashima","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.05.003_bb0260","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1172\/JCI116493","article-title":"Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase","volume":"91","author":"Targoff","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2017.05.003_bb0265","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/art.21883","article-title":"Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis\/dermatomyositis","volume":"54","author":"Yamasaki","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.003_bb0270","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.autrev.2012.06.006","article-title":"Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity","volume":"12","author":"Hervier","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.05.003_bb0275","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/ard.2005.040717","article-title":"Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen","volume":"65","author":"Hengstman","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.003_bb0280","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/art.24621","article-title":"RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease","volume":"60","author":"Sato","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.003_bb0285","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/acr.21985","article-title":"Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis","volume":"65","author":"Chen","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2017.05.003_bb0290","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/art.22164","article-title":"A novel autoantibody to a 155-kd protein is associated with dermatomyositis","volume":"54","author":"Targoff","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.003_bb0295","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.33403","article-title":"Myositis-specific anti-155\/140 autoantibodies target transcription intermediary factor 1 family proteins","volume":"64","author":"Fujimoto","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.003_bb0300","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1136\/annrheumdis-2011-200871","article-title":"Anti-TIF1gamma antibodies (anti-p155) in adult patients with dermatomyositis: comparison of different diagnostic assays","volume":"71","author":"Labrador-Horrillo","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.003_bb0305","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1212\/WNL.0000000000002863","article-title":"Anti-TIF1-gamma antibody and cancer-associated myositis: a clinicohistopathologic study","volume":"87","author":"Hida","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2017.05.003_bb0310","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/art.24547","article-title":"Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis","volume":"60","author":"Gunawardena","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.003_bb0315","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/annrheumdis-2011-200697","article-title":"Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy","volume":"71","author":"Ichimura","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.003_bb0320","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1136\/ard.2008.097162","article-title":"Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis","volume":"68","author":"Betteridge","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.003_bb0325","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaut.2014.01.008","article-title":"The diagnosis and classification of mixed connective tissue disease","volume":"48\u201349","author":"Tani","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.05.003_bb0330","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.autrev.2012.06.004","article-title":"Overlap connective tissue disease syndromes","volume":"12","author":"Iaccarino","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.05.003_bb0335","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.autrev.2006.08.007","article-title":"Anti-RNP immunity: implications for tissue injury and the pathogenesis of connective tissue disease","volume":"6","author":"Keith","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.05.003_bb0340","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1172\/JCI108616","article-title":"Antinuclear antibody with distinct specificity for polymyositis","volume":"59","author":"Wolfe","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2017.05.003_bb0345","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/art.38428","article-title":"Clinical and serologic correlates of anti-PM\/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients","volume":"66","author":"D'Aoust","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.003_bb0350","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/S0021-9258(17)35929-X","article-title":"Characterization of the DNA-binding protein antigen Ku recognized by autoantibodies from patients with rheumatic disorders","volume":"261","author":"Mimori","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2017.05.003_bb0355","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1212\/WNL.0000000000002291","article-title":"Hepatitis C virus infection in inclusion body myositis: a case-control study","volume":"86","author":"Uruha","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2017.05.003_bb0360","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ana.23840","article-title":"Cytosolic 5\u2032-nucleotidase 1A autoimmunity in sporadic inclusion body myositis","volume":"73","author":"Larman","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2017.05.003_bb0365","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ana.23822","article-title":"Autoantibodies to cytosolic 5\u2032-nucleotidase 1A in inclusion body myositis","volume":"73","author":"Pluk","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2017.05.003_bb0370","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/annrheumdis-2014-206691","article-title":"Disease specificity of autoantibodies to cytosolic 5\u2032-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases","volume":"75","author":"Herbert","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.003_bb0375","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/brain\/aws106","article-title":"Inflammatory myopathies associated with anti-mitochondrial antibodies","volume":"135","author":"Maeda","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2017.05.003_bb0380","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamaneurol.2014.775","article-title":"Autoimmune aquaporin-4 myopathy in neuromyelitis optica spectrum","volume":"71","author":"Guo","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2017.05.003_bb0385","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1172\/JCI81031","article-title":"Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies","volume":"125","author":"Albrecht","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2017.05.003_bb0390","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.autrev.2014.08.038","article-title":"Identification of a novel myositis-associated antibody directed against cortactin","volume":"13","author":"Labrador-Horrillo","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.05.003_bb0395","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.autrev.2014.08.037","article-title":"Cortactin: a new target in autoimmune myositis and Myasthenia gravis","volume":"13","author":"Berrih-Aknin","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.05.003_bb0400","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1212\/WNL.0000000000001767","article-title":"Plasma IP-10 level distinguishes inflammatory myopathy","volume":"85","author":"Uruha","year":"2015","journal-title":"Neurology"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217301234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217301234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T06:41:49Z","timestamp":1657780909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997217301234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":80,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1568997217301234"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2017.05.003","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated Diagnosis Project for Inflammatory Myopathies: An association between autoantibodies and muscle pathology","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2017.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}